In the late 19th century, Nikolai Tesla pioneered the use of electro-magnetism as a treatment for various illnesses and diseases. Tesla - and many doctors - believed “complimentary healing frequencies” could neutralize diseases, bacteria and the harmful effects of EMF radiation.

Today, Tesla’s invention is known as “pulsed electromagnetic field therapy,” or PEMF. Fox’s device, called the Pulsar XO, is now available for sale through his company, Resona Health.

Fox – and many others - believe PEMF is effective to relieve people suffering a wide range of ailments, from allergies and arthritis to PMS and PTSD. He says that he hopes PEMF will free sufferers from dependence on pharmaceuticals and/or surgery.

Tesla was reported to have treated a wide range of ailments with great success. However, he also made powerful enemies who opposed his research: the American Medical Association, (AMA) and the Carnegie Foundation.

In 1910, the Carnegie Foundation funded a report - on behalf of the AMA – designed to drive Tesla out of the healing business. The report detailed the “preferred medical education” for physicians in North America. The AMA used the report to create a list of “authorized” medical schools and forbade them to teach Tesla’s electrotherapy. At the same time, the Carnegie Foundation threatened to withhold funding from any medical school that promoted electrotherapy.

Since doing so would put their funding at risk, medical schools declined to teach electrotherapy. As a result, additional medical research into Tesla’s technology all but ceased. Anyone who studied or tested electrotherapy had to do so from outside “official” medicine.

Naysayers warned about the dangers posed by extended exposure to electro-magnetism. Yet no one experienced more electromagnetic exposure than Tesla himself. Tesla should have been the most obvious victim. However, when he died in 1943, he was 86 years old, far older than the average life-expectancy of 65 at the time of his death.

Mark Fox is far from the first scientist to try to harness Tesla's PEMF research for the purposes of healing. Many other notable figures have invented therapeutic devices based on electro-magnetism. These include Royal Rife's Rife Machine, Antoine Priore's Priore Machine, Rife's assistant John Crane, who advanced Rife's work with his Model CFR-1000, Gianno Dotto's Dotto Ring, George Lakhovsky’s unnamed machine described in US Patent 2,351,055, and the man who invented Lockheed's satellite guidance system, Evans Rapsomanikis.

(Famous movie tough-guy James Coburn claims a Rapsomanikis machine cured his rheumatoid arthritis.)

All the inventors had backgrounds in electrical engineering. All their machines were based on Tesla’s ideas about the function of electro-magnetism in healing cells. However, all the machines were wildly expensive and required experts to administer the treatments.

With his engineering background, Fox recognized that Tesla’s ideas were fundamentally sound. Yet if PEMF had any chance to disrupt the modern medical paradigm, he knew it had to be made accessible to the masses.

Fox realized that he could modify common consumer electronic devices – namely Bluetooth speakers and MP3 players - to generate pulsed electromagnetic frequencies. Though the strength of the PEMF waves would be lower than the expensive, high-powered machines, the actual PEMF waveforms would be identical, and research has shown higher strength fields are not necessary for relief.

The device he created, the Pulsar XO, is an “FDA low-risk general wellness device.” It is available now for consumer use, as well as for at-home pilot studies.

For a list of therapies currently available with the Pulsar XO, see the Resona.Health website under “Protocols.” Current Home Pilot Studies can be found on the web site as well and include PTSD, Migraines, and Weightloss.

For details and additional information, contact Resona Health at info@resona.health.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News at the speed of influence™. Reference URL for this press release is here.